par Agathe Masson | Mar 31, 2025 | Access to Care, NCD Policy, Actualités
Noncommunicable diseases (NCDs) are among the leading causes of death and disability worldwide, posing an immense burden on healthcare systems, economies, and individuals—especially in countries with a low Human Development Index (HDI). Recognising the urgency of...
par Agathe Masson | Mar 13, 2025 | Access to Care, NCD Partnerships, Actualités
A new article in The Lancet Oncology1 highlights the urgent need for sustainable solutions to improve cancer treatment access in low- and middle-income countries (LMICs). Authored by ATOM Coalition experts, the article outlines key barriers to medicine availability...
par Agathe Masson | Jan 29, 2025 | Access to Care, Healthcare Systems, Actualités
Cervical cancer remains one of the most preventable and treatable cancers. Yet it disproportionately affects women in countries with low Human Development Index (HDI), where screening and treatment services often face systemic challenges. Recognising this, the World...
par Agathe Masson | Déc 17, 2024 | NCD Case Studies, NCD Partnerships, Actualités
Following the agreement on a new licensing model between the Medicines Patent Pool (MPP) & Novartis in collaboration with the ATOM Coalition, generic, quality-assured nilotinib is now available on NCDconnect! This initiative is crucial in making lifesaving...
par Agathe Masson | Déc 16, 2024 | NCD Solutions, Actualités
Welcome to NCDconnect, your Digital Procurement Platform for essential medicines and medical devices against noncommunicable diseases (NCD). Signing up is straightforward, and this guide will help you complete the process with ease. For visual assistance, check out...
par Agathe Masson | Déc 13, 2024 | Access to Care, NCD Solutions, Actualités
Every child deserves a fighting chance against cancer, regardless of where they are born. Yet, stark inequalities persist in access to pediatric oncology treatment, especially in low- and middle-income countries (LMICs). As purchasers responsible for securing...
